SIBOLD WILLIAM JOHN (President and CEO) sold 1.2% of their position (2.50K shares) of MADRIGAL PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $1.37M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+50K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
−140.00
Price / share
$542.75
Trade value
$75.98K
% of position
Common Stock
Shares
−110.00
Price / share
$543.79
Trade value
$59.82K
% of position
Common Stock
Shares
−545.00
Price / share
$544.71
Trade value
$296.87K
% of position
Common Stock
Shares
−275.00
Price / share
$545.71
Trade value
$150.07K
% of position
Common Stock
Shares
−269.00
Price / share
$547.08
Trade value
$147.16K
% of position
Common Stock
Shares
−680.00
Price / share
$547.70
Trade value
$372.43K
% of position
Common Stock
Shares
−47.00
Price / share
$548.87
Trade value
$25.80K
% of position
Common Stock
Shares
−153.00
Price / share
$550.01
Trade value
$84.15K
% of position
Common Stock
Shares
−1.00
Price / share
$550.72
Trade value
$550.72
% of position
Common Stock
Shares
−280.00
Price / share
$555.05
Trade value
$155.41K
% of position
Net shares
+47.50K
Net value
-$1.37M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/17/2026 | M · Option Exercise | +50K | — | — | 30.9% | 161.83K | 211.83K |
| Common Stock Direct | 7/20/2026 | S · Sale | −140.00 | $542.75 | $75.98K | 0.1% | 211.83K | 211.69K |
| Common Stock Direct | 7/20/2026 | S · Sale | −110.00 | $543.79 | $59.82K | 0.1% | 211.69K | 211.58K |
| Common Stock Direct | 7/20/2026 | S · Sale | −545.00 | $544.71 | $296.87K | 0.3% | 211.58K | 211.03K |
| Common Stock Direct | 7/20/2026 | S · Sale | −275.00 | $545.71 | $150.07K | 0.1% | 211.03K | 210.76K |
| Common Stock Direct | 7/20/2026 | S · Sale | −269.00 | $547.08 | $147.16K | 0.1% | 210.76K | 210.49K |
| Common Stock Direct | 7/20/2026 | S · Sale | −680.00 | $547.70 | $372.43K | 0.3% | 210.49K | 209.81K |
| Common Stock Direct | 7/20/2026 | S · Sale | −47.00 | $548.87 | $25.80K | 0.0% | 209.81K | 209.76K |
| Common Stock Direct | 7/20/2026 | S · Sale | −153.00 | $550.01 | $84.15K | 0.1% | 209.76K | 209.61K |
| Common Stock Direct | 7/20/2026 | S · Sale | −1.00 | $550.72 | $550.72 | 0.0% | 209.61K | 209.61K |
| Common Stock Direct | 7/20/2026 | S · Sale | −280.00 | $555.05 | $155.41K | 0.1% | 209.61K | 209.33K |
| Total | +47.50K | -$1.37M | ||||||
Performance Restricted Stock Units
Common Stock
50K shares
Shares
−50K
Strike price
Held after
0.00
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Performance Restricted Stock Units Direct | Common Stock50K shares | 7/17/2026 | M · Option Exercise | −50K | — | 0.00 |